DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > Spectrum Pharmaceuticals Aktie > Nachrichten zu Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Aktie [WKN: 164623 / ISIN: US84763A1088]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Spectrum Pharmaceuticals IncShs . Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Spectrum Pharmaceuticals IncShs

07.02.12Spectrum Pharmaceuticals to Present at the BIO CEO Investor Conference
31.01.12Spectrum Pharmaceuticals In-Licenses a Novel, Long-Acting GCSF Drug in U.S. Clinical Trials from Hanmi Pharmaceuticals
27.01.12Spectrum Pharmaceuticals Strengthens Commercial Operations
25.01.12Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN®
23.01.12ZEVALIN Plus High Dose Chemotherapy (Z-BEAM) Highly Effective in Aggressive Lymphoma; Randomized Study Published in "CANCER”, the Journal of the American Cancer Society
04.01.12Spectrum Pharmaceuticals to Present at the J. P. Morgan Healthcare Conference
12.12.11Impressive ZEVALIN® Data Highlighted at 53rd Annual Meeting of the American Society of Hematology; Spectrum to Increase Clinical Efforts to Expand ZEVALIN Indications
12.12.11Multifaceted Repositioning Campaign for ZEVALIN® Unveiled at ASH 2011, Following Recent FDA Approval to Remove Bioscan Requirement
09.12.11Spectrum Pharmaceuticals Affirms Strong Patent Protection for FUSILEV® (levoleucovorin) Through December 31, 2019
09.12.11Spectrum Pharmaceuticals Announces 19 ZEVALIN Presentations at the 53rd Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 10-13, 2011
09.12.11Ecolab China Again Named Outstanding Enterprise for Corporate Social Responsibility by China Business News
07.12.11Spectrum Pharmaceuticals to Present at the Oppenheimer & Co. 22nd Annual Healthcare Conference
05.12.11Spectrum Pharmaceuticals Files IND Application with U.S. FDA for SPI-014
05.12.11Dollar General Corporation Reports Record Third Quarter Sales and Earnings; Announces $500 Million Share Repurchase Authorization
28.11.11Spectrum Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell on Tuesday, November 29, 2011
22.11.11Trend-Aktien Fehlanzeige? - 3 US-Kursraketen im Check! - Teil 2
21.11.11FDA Approves the Removal of the Bioscan Requirement for ZEVALIN® Treatment
09.11.11Spectrum Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
24.10.11Spectrum Pharmaceuticals Announces Date and Time for Its Third Quarter and Nine-Month 2011 Financial Results Conference Call
28.09.11Spectrum Pharmaceuticals Strengthens Commercial Operations with Appointment of Brian Holzer MD, MBA as Executive Director of Brand Management
26.09.11Spectrum Pharmaceuticals Completes Enrollment in the Belinostat Pivotal Trial for Relapsed/Refractory Peripheral T-Cell Lymphoma
26.09.11Fuel Tech Awarded Air Pollution Control Orders Totaling $3.0M
26.09.11The Washington Post Introduces All-New "D.C. Going Out Guide” App for iPhone
23.09.11Spectrum Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
20.09.11GE’s Field-Proven and Flexible Technology to Help OGX Develop Offshore Brazil Oil Fields
20.09.11Spectrum Pharmaceuticals Receives Approximately $25 Million from Warrant Exercise
20.09.11General Finance Corporation Reports Fourth Quarter and Full Year 2011 Results
20.09.11GE Energy Announces More than $3 Billion in New Customer Agreements
19.09.11Spectrum Pharmaceuticals Announces Impressive Responses in Difficult to Treat Carcinomas with SPI-1620 in a Phase I Study
16.09.11Spectrum Pharmaceuticals to Present at the UBS Global Life Sciences Conference
13.09.11Spectrum Pharmaceuticals Initiates Stock Repurchase Program
09.09.11Spectrum Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
01.09.11Spectrum Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
01.09.11Local.com Named Preferred Supplier to PAGE Cooperative
27.07.11Spectrum Pharmaceuticals Announces Date and Time for Its Second Quarter and Six-Month 2011 Financial Results Conference Call
21.06.11Spectrum Pharmaceuticals Has Ample Supplies of FUSILEV® to Meet the Growing Demand of Colorectal Cancer Patients in the U.S.
20.06.11Spectrum Pharmaceuticals’ ZEVALIN® Was Highlighted During Oral Presentations and Abstracts at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland
15.06.11Spectrum Pharmaceuticals Announces Authorization of Stock Repurchase Program up to $25 Million
14.06.11Spectrum Pharmaceuticals Announces Results of Annual Meeting of Shareholders
13.06.11Spectrum Pharmaceuticals’ Chairman and Chief Executive Officer Named an Ernst & Young Orange County Region Entrepreneur of the Year® Award Winner

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon